Rating History for ORIC Pharmaceuticals (ORIC) by Goldman Sachs
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/4/2025 | Corinne Johnson | New Coverage | Early-Stage Biotech (N/A) |
N/A (N/A) |
10.98 (13.71) |
24.86% | Details |
